FDA grants PMA to Synergy’s cervical disc
Synergy Spine Solutions has received premarket approval (PMA) from the US Food and Drug Administration (FDA) for the Synergy Disc, …
Post
-
-
Thermo Fisher launches LDT to support tailored immunosuppressant dosing
Thermo Fisher Scientific has launched a new laboratory-developed test (LDT) to guide clinicians in their dosing of tacrolimus, a commonly …
-
Ottobock invests $5m in Blue Arbor for prosthetic control advancement
Blue Arbor Technologies and German prosthetics company Ottobock have partnered to advance clinical and commercial activities for the former’s prosthetic …
-
Academia Sinica and NTU Hospital develop AI model for pancreatic cancer
Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early …
-
ENDRA reports favourable data from Taeus Liver device study in MASLD
ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in metabolic …
-
Knight Therapeutics advances chronic GvHD expansion strategy
Knight Therapeutics has announced the regulatory submission of Niktimvo (axatilimab) in Brazil for the treatment of chronic graft-versus-host disease (cGvHD), …
-
GE HealthCare launches general imaging ultrasound systems
GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite workflows. The new systems …
-
Quantum acquires NeuWave Medical to enhance tumour ablation treatments
Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer …
-
TECLens begins first-in-human trial for qCXL vision correction technology
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering …
-
Medtronic’s diabetes business MiniMed looks for $784m in US IPO
Diabetes specialist MiniMed has launched an initial public offering (IPO) to bolster its capital reserve amid its ongoing split from …
-
Stryker unveils Synchfix EVT for flexible syndesmotic ankle fixation
US-based Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation …
-
MiraDx expands predictive oncology testing arsenal with Prostox Standard
California-based molecular diagnostics company MiraDx has added Prostox Standard to its portfolio – marking another US launch in the company’s …
-
Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio
Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio. The agreement is intended to …
-
FDA approves Allurion’s PMA application for Gastric Balloon System
Allurion has received the US Food and Drug Administration (FDA) clearance for premarket approval (PMA) application for its Gastric Balloon …
-
Guardant Health acquires MetaSight amid positive 2026 financial outlook
Cancer diagnostics specialist Guardant Health has completed its $149m acquisition of health technology company, MetaSight Diagnostics, as the company gears …
